Literature DB >> 26022692

Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?

Manuela Merli1, Srinivasan Dasarathy2.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26022692     DOI： 10.1016/j.jhep.2015.05.014

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  Are Exercise Benefits in Nonalcoholic Fatty Liver Disease Due to Increased Autophagy?

Authors:  Srinivasan Dasarathy
Journal:  Exerc Sport Sci Rev       Date:  2017-07       Impact factor: 6.230

2.  Exercise-Induced Autophagy in Fatty Liver Disease.

Authors:  Sung Kook Chun; Sooyeon Lee; Ming-Jim Yang; Christiaan Leeuwenburgh; Jae-Sung Kim
Journal:  Exerc Sport Sci Rev       Date:  2017-07       Impact factor: 6.230

Review 3.  Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients.

Authors:  Renyi Su; Xuyong Wei; Qiang Wei; Di Lu; Zuyuan Lin; Shuo Wang; Chuxiao Shao; Xiao Xu
Journal:  Hepatobiliary Surg Nutr       Date:  2022-06       Impact factor: 8.265

4.  Diet-Induced Nonalcoholic Fatty Liver Disease Is Associated with Sarcopenia and Decreased Serum Insulin-Like Growth Factor-1.

Authors:  Daniel Cabrera; Alex Ruiz; Claudio Cabello-Verrugio; Enrique Brandan; Lisbell Estrada; Margarita Pizarro; Nancy Solis; Javiera Torres; Francisco Barrera; Marco Arrese
Journal:  Dig Dis Sci       Date:  2016-08-29       Impact factor: 3.199

5.  Exercise and physical activity in cirrhosis: opportunities or perils.

Authors:  Annette Bellar; Nicole Welch; Srinivasan Dasarathy
Journal:  J Appl Physiol (1985)       Date:  2020-04-02

6.  Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.

Authors:  Cristiane V Tovo; Sabrina A Fernandes; Caroline Buss; Angelo A de Mattos
Journal:  World J Hepatol       Date:  2017-02-28

7.  Association between muscle strength and advanced fibrosis in non-alcoholic fatty liver disease: a Korean nationwide survey.

Authors:  Sunyoung Kang; Min Kyong Moon; Won Kim; Bo Kyung Koo
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-07       Impact factor: 12.910

Review 8.  Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis.

Authors:  Manu V Chakravarthy; Mohammad S Siddiqui; Mikael F Forsgren; Arun J Sanyal
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-23       Impact factor: 5.555

Review 9.  Sarcopenia and risk of nonalcoholic fatty liver disease: A meta-analysis.

Authors:  Karn Wijarnpreecha; Panadeekarn Panjawatanan; Charat Thongprayoon; Veeravich Jaruvongvanich; Patompong Ungprasert
Journal:  Saudi J Gastroenterol       Date:  2018 Jan-Feb       Impact factor: 2.485

Review 10.  Nonalcoholic Fatty Liver Disease and Sarcopenia: Where Do We Stand?

Authors:  Ivana Mikolasevic; Tajana Pavic; Tajana Filipec Kanizaj; Darija Vranesic Bender; Viktor Domislovic; Zeljko Krznaric
Journal:  Can J Gastroenterol Hepatol       Date:  2020-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.